• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

International Alliance

  • Profile
  • Topics Started
  • Replies Created
  • Engagements
  • Favorites

Favorite Forum Topics

  • Oh, bother! No topics were found here.

Primary Sidebar

Advocacy

  • Advocacy Toolkit

Approved Drugs

  • Nuedexta
  • Radicava/Edaravone
  • Riluzole/Tiglutik
  • Rozebalamin / Methylcobalamin
  • Tofersen/Qalsody

Drugs in Development

  • AB Science – Masitinib
  • NurOwn
  • Clene Nanomedicine – CNM-Au8
  • ILB
  • Kadimastem – AstroRx
  • Neuronata-R / Lenzumestrocel
  • NeuroSense – PrimeC
  • NP001
  • Prilenia Therapeutics – Pridopidine
  • SOD1 Therapies & Trials
  • SPG302
  • Regulatory T Cell Enhancing Therapies
  • Ulefnersen

Care services

  • Genetic Counselling & Testing
  • Mental Health Support
  • Nursing and Symptom Management
  • Nutrition and Swallowing
  • Occupational Therapy and Activities of Daily Living
  • Physiotherapy and Mobility
  • Respiratory Care
  • Speech Therapy and Communication
  • Support for Family & Caregivers
  • Technology

Support for members

  • Alliance Support Grant
  • About the meetings

Events/Programs

  • Calendar of Events/Programs
  • Alliance Webinars
  • Alliance Meeting
  • Allied Professionals Forum
  • ALS/MND Connect
  • Global Day Calendar
  • March of Faces
  • International Symposium

About

  • Who We Are
  • Board of Trustees
  • Councils, Forums & Committees
    • PALS and CALS Advisory Council
    • Scientific Advisory Council
    • Advocacy and Public Policy Forum
    • Research Directors Forum
    • Governance Committee
    • Finance Committee
  • Staff
  • History
  • Newsletter Archive
    • Newsletters
    • Meetings
  • Awards

Upcoming Events

Aug 19
8:00 am - 9:00 am EDT

Member Forum: Equitable Access to Care

Aug 19
6:00 pm - 7:00 pm EDT

Member Forum: Equitable Access to Care

Aug 20
11:00 am - 12:00 pm EDT

ALS-FTD Clinicopathological Overlap

Sep 8
8:00 am - 9:00 am EDT

Member Forum: Health Literacy

Sep 8
6:00 pm - 7:00 pm EDT

Member Forum: Health Literacy

View Calendar

  • Marcel R. Wernard, Netherlands

    Marcel R. Wernard, Netherlands

  • Graham Johnson, Australia

    Graham Johnson, Australia

  • Rosie Riley, USA

    Rosie Riley, USA

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Vincent Bourque, Canada

    Vincent Bourque, Canada
    vincent_bourque

  • Rolf Mauch, Switzerland

    Rolf Mauch, Switzerland

  • Seckin McGuirk, England

    Seckin McGuirk, England

  • Jon Newsome, USA

    Jon Newsome, USA

  • Rob Tison, USA

    Rob Tison, USA

  • Claudia Gotti, Brazil

    Claudia Gotti, Brazil

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Amparo Muriel Engativa, Colombia

    Amparo Muriel Engativa, Colombia

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Lachlan Terry, Australia

    Lachlan Terry, Australia

  • Shay Rishoni, Israel

    Shay Rishoni, Israel

  • John Sweeney, USA

    John Sweeney, USA

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Gudjon Sigurdsson, Iceland

    Gudjon Sigurdsson, Iceland

  • Ali Var, Turkey

    Ali Var, Turkey

  • Ana María Zavala, Mexico

    Ana María Zavala, Mexico

  • Angie Bordaen, Belgium

    Angie Bordaen, Belgium

  • Hollister

    Hollister
    hollister

  • Charlie Dourney, USA

    Charlie Dourney, USA

  • Shay Rishoni, Netherlands

    Shay Rishoni, Netherlands

  • Sharon Corosanite, USA

    Sharon Corosanite, USA

  • Hiroshi Matsuyama, Japan

    Hiroshi Matsuyama, Japan

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Mike Cels, Canada

    Mike Cels, Canada

  • Joy Blakeley, Australia

    Joy Blakeley, Australia

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Wilfried Leusing, Germany

    Wilfried Leusing, Germany

  • Dick Dayton, USA

    Dick Dayton, USA

  • Eric Von Schaumburg, USA

    Eric Von Schaumburg, USA

  • Steve Gallagher, Canada

    Steve Gallagher, Canada
    Picture1

  • Diana Fernandez, Argentina

    Diana Fernandez, Argentina

  • Jay Epstein, USA

    Jay Epstein, USA

  • Dawn Morton, Scotland

    Dawn Morton, Scotland

  • Maurice LeClerc, Canada

    Maurice LeClerc, Canada

  • Ian Gale, Australia

    Ian Gale, Australia

  • Sally Pauls, USA

    Sally Pauls, USA

  • John Dinon, Australia

    John Dinon, Australia

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Jorge Luis Fernández Romero, Mexico

    Jorge Luis Fernández Romero, Mexico

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Oscar Mauricio Linares, Colombia

    Oscar Mauricio Linares, Colombia

  • Susan Anderson, USA

    Susan Anderson, USA

  • Laurie Petit-Jean, France

    Laurie Petit-Jean, France

Learn more about the March of Faces

Coronavirus (COVID-19) Resources

Instructions

First-time users, please register by clicking the register button below this log in form. You will then be able to create a user name and password. Only Alliance members are eligible to register.

If you have already registered, please use the details provided to log in using this form.

Drugs No Longer in Development

  • AMX0035
  • Reldesemtiv
  • Arimoclomol
  • TUDCA

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login